Loading clinical trials...
Loading clinical trials...
Follow-up Study to Assess Visual Function in Subset of Patients Who Have Previously Participated in the TG-MV-006 and TG-MV-007 Ocriplasmin Studies.
Conditions
Interventions
ocriplasmin
placebo
Locations
2
United States
Retinal Consultants of Houston
Houston, Texas, United States
Universitaire Ziekenhuizen K.U. Leuven
Leuven, Belgium
Start Date
May 1, 2011
Primary Completion Date
October 1, 2011
Completion Date
October 1, 2011
Last Updated
January 13, 2017
Lead Sponsor
ThromboGenics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions